WILLIAM RAMSES BISHAI, M.D.
Osteopathic Medicine at Wolfe St, Baltimore, MD
License number
Maryland D41333
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-1725
Personal information
See more information about WILLIAM RAMSES BISHAI at radaris.comName
Address
Phone
1202 Ridervale Rd, Towson, MD 21204
900 37Th St, Baltimore, MD 21218
1202 Ridervale Rd, Towson, MD 21204
Professional information
Dr. William R Bishai, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
1550 Orleans St SUITE 108, Baltimore 21287
(410) 955-3507 (Phone), (410) 614-8173 (Fax)
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
1550 Orleans St, Baltimore 21287
(410) 955-9680 (Phone)
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-5080 (Phone), (410) 955-1464 (Fax)
JHU ORTHOPAEDIC SURGERY
600 N Wolfe St, Baltimore 21287
(410) 955-1719 (Phone), (410) 955-3870 (Fax)
(410) 955-3507 (Phone), (410) 614-8173 (Fax)
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
1550 Orleans St, Baltimore 21287
(410) 955-9680 (Phone)
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-5080 (Phone), (410) 955-1464 (Fax)
JHU ORTHOPAEDIC SURGERY
600 N Wolfe St, Baltimore 21287
(410) 955-1719 (Phone), (410) 955-3870 (Fax)
Certifications:
Infectious Disease, 1994, Internal Medicine, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1550 Orleans St SUITE 108, Baltimore 21287
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
1550 Orleans St, Baltimore 21287
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
JHU ORTHOPAEDIC SURGERY
600 N Wolfe St, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
1550 Orleans St, Baltimore 21287
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
JHU ORTHOPAEDIC SURGERY
600 N Wolfe St, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
Harvard Medical School
Graduated: 1989
Brigham and Women's Hospital
Harvard Medical School
Graduated: 1989
Brigham and Women's Hospital
William Ramses Bishai, Baltimore MD
Specialties:
Internal Medicine, Infectious Disease
Work:
The Johns Hopkins Hospital
600 N Wolfe St, Baltimore, MD 21287 Johns Hopkins Outpatient Center
601 N Caroline St, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287 Johns Hopkins Outpatient Center
601 N Caroline St, Baltimore, MD 21287
Education:
Harvard University(1989)
William Ramses Bishai, Baltimore MD
Specialties:
Internist
Address:
600 N Wolfe St, Baltimore, MD 21287
1550 Orleans St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
1550 Orleans St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Whmd, An Essential Cell Division Gene From Mycobacteria
US Patent:
6590087, Jul 8, 2003
Filed:
May 25, 2000
Appl. No.:
09/577934
Inventors:
William R. Bishai - Baltimore MD
James E. Gomez - Baltimore MD
James E. Gomez - Baltimore MD
Assignee:
Johns Hopkins University - Baltimore MD
International Classification:
C07H 2102
US Classification:
536 231, 536 234, 536 235, 536 237, 4353201, 435 691, 4352523, 4352521
Abstract:
A whmD gene that controls sporulation in mycobacteria, vectors and transformed cells containing the gene.
Regulation Of A Sigma Factor From Mycobacterium Tuberculosis
US Patent:
5824546, Oct 20, 1998
Filed:
Mar 27, 1996
Appl. No.:
8/622352
Inventors:
William R. Bishai - Baltimore MD
James DeMaio - Tacoma WA
James DeMaio - Tacoma WA
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
C12N 510, C12N 100, C12N 1531, C12N 1563
US Classification:
435325
Abstract:
Two genes, orfX and orfY, regulate sigF expression and sigF activity in M. tuberculosis. M. tuberculosis sigF, orfX, and orfY are used in screening methods for potential therapeutic agents which regulate the growth of M. tuberculosis.
Method Of Identifying Compounds That Regulate The Binding Of M. Tuberculosis Sigf To M. Tuberculosis Orfx
US Patent:
6004764, Dec 21, 1999
Filed:
Apr 9, 1997
Appl. No.:
8/826390
Inventors:
William R. Bishai - Baltimore MD
Douglas B. Young - London, GB
Ying Zhang - Baltimore MD
James DeMaio - Tacoma WA
Douglas B. Young - London, GB
Ying Zhang - Baltimore MD
James DeMaio - Tacoma WA
Assignee:
Johns Hopkins University - Baltimore MD
International Classification:
G01N 33566
US Classification:
435 78
Abstract:
sigF is a gene that controls M. tuberculosis latency. A diagnostic test for latent tuberculosis involves detecting M. tuberculosis sigF in clinical specimens. Two genes orfX and orfY regulate sigF expression and sigF activity. M. tuberculosis sigF, orfX, and orfY are used in screening methods for potential therapeutic agents which regulate the growth of M. tuberculosis.
Hollow Fiber Technique For In Vivo Study Of Cell Populations
US Patent:
2006018, Aug 17, 2006
Filed:
Sep 6, 2005
Appl. No.:
11/221294
Inventors:
William Bishai - Baltimore MD, US
Petros Karakousis - Lutherville MD, US
Petros Karakousis - Lutherville MD, US
International Classification:
A61K 49/00, C12Q 1/00
US Classification:
424009200, 435004000
Abstract:
The present invention relates to a method of using hollow fibers to evaluate cellular changes in vivo. A method for evaluating cellular changes in vivo in response to administration of a drug or drugs of interest is provided. The hollow fiber technique is also used to evaluate cellular changes in a microorganism in vivo. The technique is further used to evaluate cellular changes in a microorganism in vivo in response to administration of a drug or drugs of interest. A vaccine and method of vaccination are also provided.
Rationally Improved Isoniazid And Ethionamide Derivatives And Activity Through Selective Isotopic Substitution
US Patent:
2011021, Sep 8, 2011
Filed:
Aug 20, 2008
Appl. No.:
12/674188
Inventors:
Graham Timmins - Albuquerque NM, US
Sharon Master - Albuquerque NM, US
Vojo P. Deretic - Placitas NM, US
William Bishai - Towson MD, US
Sharon Master - Albuquerque NM, US
Vojo P. Deretic - Placitas NM, US
William Bishai - Towson MD, US
Assignee:
STC.UNM - Albuquerque NM
THE JOHN HOPKINS UNIVERSITY - Baltimore MD
THE JOHN HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61K 31/4409, C07D 213/83, C07D 213/81, C07D 213/86, A61P 31/06
US Classification:
514354, 546313, 546323, 546324, 514357
Abstract:
The present invention relates to the use of isotopically labeled derivatives of isoniazid, ethionamide and related compounds as effective therapy for the treatment of mycobacterial diseases, including
Methods For Treatment Of Bacterial Infections
US Patent:
2012011, May 10, 2012
Filed:
Oct 27, 2011
Appl. No.:
13/283406
Inventors:
Gyanu Lamichhane - Towson MD, US
William R. Bishai - Towson MD, US
Radhika Gupta - Uttar Pradesh, IN
Marie Lavollay - Bourg La Reine, FR
Jean-Luc Mainardi - Chaville, FR
Michel Arthur - Arcueil, FR
William R. Bishai - Towson MD, US
Radhika Gupta - Uttar Pradesh, IN
Marie Lavollay - Bourg La Reine, FR
Jean-Luc Mainardi - Chaville, FR
Michel Arthur - Arcueil, FR
Assignee:
CENTRE DE RECHERCHE DES CORDELIERS - PARIS
THE JOHNS HOPKINS UNIVERSITY - BALTIMORE MD
THE JOHNS HOPKINS UNIVERSITY - BALTIMORE MD
International Classification:
A61K 31/43, A61K 31/424, A61P 31/04, A61K 31/407
US Classification:
514197, 5142101, 51421013, 51421006
Abstract:
The peptidoglycan layer is a vital component of the bacterial cell wall, which comprises 4→3 and 3→3 transpeptide cross-linkages, the formation of which are catalyzed by D,D- and L,D-transpeptidases, respectively. Methods for the treatment of bacterial infections with agents that inhibit L,D-transpeptidases, either alone or in combination with D,D-transpeptidase inhibitors, are provided herein. Also provided are methods for the treatment of chronic stage tuberculosis with agents that inhibit enzyme with L,D-transpeptidase activity.
Mycobacterium Tuberculosis Persistance Genes
US Patent:
2008024, Oct 2, 2008
Filed:
Jan 18, 2008
Appl. No.:
12/016465
Inventors:
Sanjay K. Jain - Baltimore MD, US
Gyanu Lamichhane - Baltimore MD, US
William R. Bishai - Baltimore MD, US
Gyanu Lamichhane - Baltimore MD, US
William R. Bishai - Baltimore MD, US
International Classification:
A61K 39/00, C12N 1/20, G01N 33/00, A61P 37/00
US Classification:
4241901, 4352523, 435245, 4242481, 436 86
Abstract:
Compositions and methods for preventing infections, particularly persistent, latent Mycobactial infections, are provided. The compositions and methods utilize newly identified genes (and/or corresponding gene products) that are necessary for survival of within a host.